Question 1

Registries are established for different purposes and respond to different regulating bodies.

Accepted Answer

Registries can be established for various purposes such as medical, legal, educational, and financial. Each registry may respond to different governing bodies or regulations depending on its purpose.

Question 2

The establishment of statewide cancer registries in states where population-based registries did not exist was a result of federal legislation.

Accepted Answer

The National Cancer Act of 1971 established the National Cancer Program and provided funding to establish statewide cancer registries in all states. This resulted in the establishment of population-based cancer registries in states where they did not previously exist.

Question 3

Approved cancer programs are required to publish and distribute an annual report.

Accepted Answer

Approved cancer programs are required to publish and distribute an annual report according to the Commission on Cancer's Accreditation Program Standards. The report must include information on patient volumes, outcomes, and quality improvement initiatives.

Question 4

Population-based and hospital-based cancer registries are of several types.

Accepted Answer

Population-based cancer registries collect data on all cancers that occur within a defined population, while hospital-based cancer registries collect data on cancers diagnosed and/or treated within a particular hospital or group of hospitals. Both types of registries can be further classified based on various factors such as geographical location, demographics, and cancer type.

Question 5

Staging of neoplasms is recorded at the time of initial diagnosis and treatment.

Accepted Answer

Staging of neoplasms is an important step in the diagnosis and treatment process, and is typically recorded at the time of initial diagnosis and treatment. Staging helps to determine the extent of the cancer and guide treatment decisions.

Question 6

Lifelong follow-up has been a requirement for all population-based and hospital cancer registries since their inception.

Accepted Answer

Lifelong follow-up is not a requirement for all cancer registries; practices vary by registry and region.

Question 7

Monitoring cancer incidence is legislatively mandated in most states.

Accepted Answer

The answer of Monitoring cancer incidence is legislatively mandated in...

Question 8

The registration and tracking of implantable medical devices by manufacturers is mandated by law.

Accepted Answer

The registration and tracking of implantable medical devices by manufacturers is mandated by law, such as the US FDA's Unique Device Identification (UDI) system. This is to ensure the safety and effectiveness of medical devices for patients.

Question 9

Which of the following cancer data may be released without patient authorization?

Accepted Answer

Aggregate cancer data, which refers to statistical information that combines data from multiple patients and does not identify individual patients, can be released without patient authorization. This type of data is commonly used for research, public health reporting, and planning purposes. Patient, physician, and facility data are considered individually identifiable and require patient authorization before they can be released.

Question 10

One purpose of population-based cancer registries is the investigation of the cause of cancer.

Accepted Answer

The answer of One purpose of population-based cancer registries is...

Question 11

A cancer committee must be operational before a hospital cancer program can be approved.

Accepted Answer

The Commission on Cancer (CoC) requires that a cancer committee must be active and operational before a hospital can be approved for its cancer program. The cancer committee is responsible for overseeing the cancer program and ensuring that it meets the CoC standards.

Question 12

The International Classification of Diseases for Oncology, 3rd edition (ICD-O-3) serves as the basis for developing reportable cases for registry eligibility in a hospital cancer program.

Accepted Answer

The statement is correct. ICD-O-3 is used for coding and reporting cases of cancer in many countries, including the United States. Hospitals and cancer programs use this classification system to determine which cases can be included in their cancer registry.

Question 13

Which of the following is intended to assess the annual caseload and provide each patient with a registry identification number?

Accepted Answer

The accession register is used to track the annual caseload and assign a unique identification number to each patient. The other options (follow-up, patient index, and primary site) are not specifically used for this purpose.

Question 14

The primary goal of a hospital-based cancer registry is the improvement of care to the cancer patient.

Accepted Answer

Hospital-based cancer registries collect and analyze data on cancer patients in order to improve the quality of cancer care. This includes monitoring outcomes, identifying and addressing disparities in care, and supporting research and quality improvement initiatives.

Question 15

The United Network for Organ Sharing (UNOS) has administered the contract for the nation's only Organ Procurement and Transplantation Network (OPTN) since 1986.

Accepted Answer

The statement is true. UNOS has administered the contract for the OPTN since 1986.

Question 16

The International Classification of Diseases for Oncology, 3rd edition (ICD-O-3) is published by the World Health Organization (WHO).

Accepted Answer

The International Classification of Diseases for Oncology, 3rd edition (ICD-O-3) is indeed published by the World Health Organization (WHO).

Question 17

The Surveillance, Epidemiology, and End Results (SEER) program was federally mandated.

Accepted Answer

The SEER program was established by the National Cancer Institute (NCI) in 1973 to collect and publish cancer incidence and survival data from population-based cancer registries, but it was not federally mandated.

Question 18

Federal law requires the reporting of implant problems to the Food and Drug Administration when there is a probability a device has caused a death, serious illness, or injury.

Accepted Answer

This statement is true according to federal law.

Question 19

The type of population-based cancer registry for a geographical area is determined largely by legislative mandate and funding.

Accepted Answer

The type of population-based cancer registry for a geographic area is primarily determined by legislative mandate and funding. These factors influence the scope, quality and sustainability of the registry.

Quiz 13: Data Reporting, Interpretation, and Use